AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20819623 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium/albuterol (206 microg albuterol and 36 microg ipratropium q.i.d)
Number of subjects: 122
Study 19128289 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by mental health nurses (4 weekly visits)
Number of subjects: 18
Study 19128289 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 18
Study 19128289 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by mental health nurses
Number of subjects: 18
Study 17162329 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 g soy protein
Number of subjects: 80
Study 17162329 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g soy protein
Number of subjects: 80
Study 17162329 — intervention group
Group type: COMPARATOR
Intervention: Casein (placebo)
Number of subjects: 80
Study 12802709 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergent cerclage
Number of subjects: 23
Study 12802709 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23
Study 10987850 — intervention group
Group type: EXPERIMENTAL
Intervention: PSP cybrid lines
Number of subjects: 0
Study 10987850 — intervention group
Group type: COMPARATOR
Intervention: Control cybrid set
Number of subjects: 0
Study 8799385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 32
Study 8799385 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 32
Study 8799385 — intervention group
Group type: EXPERIMENTAL
Intervention: Various body positions
Number of subjects: 32
Study 1514492 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 19
Study 1514492 — intervention group
Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 19
Study 6293939 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined carbohydrate diet
Number of subjects: 13
Study 6293939 — intervention group
Group type: COMPARATOR
Intervention: Unrefined carbohydrate diet
Number of subjects: 13
Study 31078614 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-synchronized animations in addition to music (n = 13)
Number of subjects: 28
Study 31078614 — intervention group
Group type: COMPARATOR
Intervention: Only music (control group, n = 15)
Number of subjects: 28
Study 30439783 — intervention group
Group type: EXPERIMENTAL
Intervention: AT with participants' choice of background music
Number of subjects: 48
Study 30439783 — intervention group
Group type: EXPERIMENTAL
Intervention: AT with random background music
Number of subjects: 48
Study 30439783 — intervention group
Group type: EXPERIMENTAL
Intervention: AT without music
Number of subjects: 48
Study 30439783 — intervention group
Group type: COMPARATOR
Intervention: No training or music control (watching videos without AT or music)
Number of subjects: 48
Study 27302671 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased sugar-sweetened beverage (SSB) consumption from baseline to 9 months postpartum
Number of subjects: 65
Study 24203262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous esmolol (0.5 mg/kg)
Number of subjects: 12
Study 24203262 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propranolol (10 mg, 20 mg, 80 mg)
Number of subjects: 12
Study 24203262 — intervention group
Group type: COMPARATOR
Intervention: Oral propranolol (80 mg)
Number of subjects: 12
Study 24203262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous esmolol
Number of subjects: 12
Study 22152114 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN)
Number of subjects: 47
Study 21162458 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-low dose of alcohol (0.3 g/kg)
Number of subjects: 20
Study 21162458 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol doses less than 0.5 g/kg
Number of subjects: 20
Study 21162458 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 20
Study 21162458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17982232 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 18 microg once daily
Number of subjects: 100
Study 17982232 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily plus Budesonide 200 microg twice daily
Number of subjects: 100
Study 15891595 — intervention group
Group type: EXPERIMENTAL
Intervention: One-point blood sampling at 12 min after Na18F injection
Number of subjects: 12
Study 15891595 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous blood sampling at 30 min after Na18F injection
Number of subjects: 12
Study 12204499 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (10 mg/day)
Number of subjects: 2480
Study 12204499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2480
Study 9472868 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot protection programme (index group)
Number of subjects: 2001
Study 9472868 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2001
Study 7657418 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (360 micrograms total, 90 micrograms per dose, 4 metered doses)
Number of subjects: 14
Study 7657418 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 14
Study 2765283 — intervention group
Group type: EXPERIMENTAL
Intervention: Conal anaesthesia
Number of subjects: 0
Study 2765283 — intervention group
Group type: COMPARATOR
Intervention: Conventional percutaneous anaesthesia
Number of subjects: 0
Study 30388 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 29
Study 30388 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 29
Study 30388 — intervention group
Group type: EXPERIMENTAL
Intervention: H 87/07
Number of subjects: 29
Study 30388 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol and Practolol
Number of subjects: 29
Study 30388 — intervention group
Group type: COMPARATOR
Intervention: All three beta-blockers
Number of subjects: 29
Study 31375606 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole 2.5 mg/kg alternate day
Number of subjects: 92
Study 31375606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 29017280 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 2011
Study 29017280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2011
Study 25350782 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU of cholecalciferol weekly for 8 weeks)
Number of subjects: 42
Study 24066145 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) program
Number of subjects: 1039
Study 24066145 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1039
Study 20538300 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% preoperative dietary restriction (n=17)
Number of subjects: 30
Study 20538300 — intervention group
Group type: COMPARATOR
Intervention: 4 d ad libitum regimen (n=13)
Number of subjects: 30
Study 18692823 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0
Study 18692823 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors
Number of subjects: 0
Study 18692823 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 16495450 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory-impaired patients with medial temporal lobe lesions
Number of subjects: 6
Study 16495450 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 6
Study 15566933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg every 8 hours for </=3 doses
Number of subjects: 14
Study 15566933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg every 8 hours for </=3 doses
Number of subjects: 14
Study 15566933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (both dosages)
Number of subjects: 14
Study 12089976 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% metronidazole gel
Number of subjects: 13
Study 12089976 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival scaling
Number of subjects: 13
Study 12089976 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of scaling and metronidazole gel
Number of subjects: 13
Study 12089976 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated quadrant)
Number of subjects: 13
Study 9066835 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TAA) aqueous nasal spray (220 micrograms/day)
Number of subjects: 172
Study 9066835 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TAA) aqueous nasal spray (110 micrograms/day, dose reduction allowed)
Number of subjects: 172
Study 9066835 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during the initial 4-week study) followed by TAA aqueous (220 micrograms/day)
Number of subjects: 172
Study 8341866 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-sample Wilcoxon rank sum test
Number of subjects: 0
Study 8341866 — intervention group
Group type: EXPERIMENTAL
Intervention: Barthel index
Number of subjects: 0
Study 8341866 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation
Number of subjects: 0
Study 3551617 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.5% ophthalmic solution
Number of subjects: 26
Study 3551617 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 26
Study 31660644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 60
Study 29347980 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiprone position
Number of subjects: 0
Study 29347980 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 0
Study 28099665 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational dietary intervention consisting of six counseling sessions on breastfeeding and healthy complementary feeding.
Number of subjects: 323
Study 28099665 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 323
Study 24314301 — intervention group
Group type: EXPERIMENTAL
Intervention: Audience Response System (ARS)
Number of subjects: 63
Study 24314301 — intervention group
Group type: COMPARATOR
Intervention: Control group (verbal question-and-answer session)
Number of subjects: 63
Study 22440071 — intervention group
Group type: EXPERIMENTAL
Intervention: Analytical rumination
Number of subjects: 121
Study 22440071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 121
Study 22440071 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 121
Study 22440071 — intervention group
Group type: COMPARATOR
Intervention: Control (writing about thoughts without emotion regulation instructions)
Number of subjects: 121
Study 20629568 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 18
Study 20629568 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 18
Study 18394451 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (modified Bruce protocol)
Number of subjects: 75
Study 16651912 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced pronation
Number of subjects: 75
Study 16651912 — intervention group
Group type: COMPARATOR
Intervention: Supination-flexion
Number of subjects: 75
Study 14669818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field in combination with essential oils administered for 26 weeks
Number of subjects: 0
Study 14669818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8623968 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 0.8 micrograms/kg
Number of subjects: 33
Study 8623968 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 4.5 micrograms/kg
Number of subjects: 33
Study 8623968 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 33
Study 1359666 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sedative antihistamine
Number of subjects: 35
Study 1359666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 1359666 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid
Number of subjects: 35
Study 3999380 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane anesthesia
Number of subjects: 25
Study 3999380 — intervention group
Group type: COMPARATOR
Intervention: Neurolept anesthesia
Number of subjects: 25
Study 3999380 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypotensive anesthesia with trimetaphan
Number of subjects: 25
Study 3999380 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position during surgery
Number of subjects: 25
Study 3999380 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of direct arterial pressure of dorsalis pedis artery
Number of subjects: 25
Study 3999380 — intervention group
Group type: EXPERIMENTAL
Intervention: Core temperature monitoring
Number of subjects: 25
Study 30126444 — intervention group
Group type: EXPERIMENTAL
Intervention: EMOTION intervention
Number of subjects: 602
Study 25846070 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast treatment for 9 months
Number of subjects: 2
Study 25846070 — intervention group
Group type: COMPARATOR
Intervention: Routine and placebo treatment
Number of subjects: 2
Study 25269655 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified transtibial technique
Number of subjects: 40
Study 25269655 — intervention group
Group type: COMPARATOR
Intervention: Anteromedial portal technique
Number of subjects: 40
Study 25269655 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 40
Study 22222023 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) training (8 hours)
Number of subjects: 131
Study 22222023 — intervention group
Group type: COMPARATOR
Intervention: Basic communication skills training (control condition)
Number of subjects: 131
Study 19531445 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated treatment (omitting three cycles of FSH/IUI)
Number of subjects: 503
Study 19531445 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (three cycles of CC/IUI, three cycles of FSH/IUI, up to six cycles of IVF)
Number of subjects: 503
Study 19531445 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated treatment
Number of subjects: 503
Study 18284641 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 55
Study 18284641 — intervention group
Group type: COMPARATOR
Intervention: No treatment (untreated SGA controls)
Number of subjects: 55
Study 16084166 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG (n = 500)
Number of subjects: 988
Study 16084166 — intervention group
Group type: COMPARATOR
Intervention: PCI (n = 488)
Number of subjects: 988
Study 11862171 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine (250 mg/d for 12 weeks)
Number of subjects: 25
Study 11862171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 10550134 — intervention group
Group type: COMPARATOR
Intervention: 3-hour paclitaxel infusion
Number of subjects: 563
Study 10550134 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour paclitaxel infusion
Number of subjects: 563
Study 7723466 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 2314151 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene (1 mg intravenous)
Number of subjects: 8
Study 2314151 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (1 microgram/kg)
Number of subjects: 8
Study 2314151 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (1 microgram/kg) with nalmefene pretreatment
Number of subjects: 8
Study 7401832 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% lidocaine applied to the carotid bifurcation (12 patients)
Number of subjects: 76
Study 7401832 — intervention group
Group type: COMPARATOR
Intervention: Normal saline applied to the carotid bifurcation (19 patients)
Number of subjects: 76
Study 31693275 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg
Number of subjects: 15
Study 31693275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31693275 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous exendin (9-39) 600 pmol/kg/min
Number of subjects: 15
Study 31693275 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 15
Study 30484920 — intervention group
Group type: EXPERIMENTAL
Intervention: High incision (hysterotomy performed 2 cm above the plica vesicouterina)
Number of subjects: 122
Study 30484920 — intervention group
Group type: COMPARATOR
Intervention: Low incision (hysterotomy performed 2 cm below the plica vesicouterina)
Number of subjects: 122
Study 30484920 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (high and low incision)
Number of subjects: 122
Study 28183366 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond-enriched high-fat lunch (A-HFL)
Number of subjects: 86
Study 28183366 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate lunch (HCL)
Number of subjects: 86
Study 28183366 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond-enriched diet (AED)
Number of subjects: 86
Study 28183366 — intervention group
Group type: COMPARATOR
Intervention: Nut-free control diet (NFD)
Number of subjects: 86
Study 26443654 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ simulation (ISS)
Number of subjects: 100
Study 26443654 — intervention group
Group type: COMPARATOR
Intervention: Off-site simulation (OSS)
Number of subjects: 100
Study 23598254 — intervention group
Group type: EXPERIMENTAL
Intervention: Static magnetic field stimulation (SMS) for 15 minutes
Number of subjects: 10
Study 23598254 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study 21270724 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoas compartment block (PCB)
Number of subjects: 40
Study 21270724 — intervention group
Group type: COMPARATOR
Intervention: Caudal block (group C)
Number of subjects: 40
Study 19478663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive task (easy or difficult digits backward) with postural stability measured by center of pressure parameters
Number of subjects: 44
Study 18020942 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Counseling (PAC) intervention over 13 weeks
Number of subjects: 120
Study 18020942 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Counseling (PAC) intervention
Number of subjects: 120
Study 18020942 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 120
Study 15473615 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose remifentanil (0.5 microg kg(‐1)min(‐1))
Number of subjects: 75
Study 15473615 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose remifentanil (0.25 microg kg(‐1)min(‐1))
Number of subjects: 75
Study 15473615 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil (1 microg kg(‐1)min(‐1))
Number of subjects: 75
Study 15473615 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose remifentanil
Number of subjects: 75
Study 15473615 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 75
Study 11479476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezosentan (5, 20, 50, and 100 mg over 1 hour each)
Number of subjects: 38
Study 11479476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 9496728 — intervention group
Group type: EXPERIMENTAL
Intervention: F60S (steam)
Number of subjects: 8
Study 9496728 — intervention group
Group type: COMPARATOR
Intervention: F60 (ETO)
Number of subjects: 8
Study 9496728 — intervention group
Group type: COMPARATOR
Intervention: F6 (ETO)
Number of subjects: 8
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhesus‐human reassortant rotavirus (RRV‐TV) vaccine
Number of subjects: 540
Study 14688860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus-related episodes of diarrhoea
Number of subjects: 540
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: All diarrhoeal episodes
Number of subjects: 540
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus-related episodes
Number of subjects: 540
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus serotype 1
Number of subjects: 540
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed infections
Number of subjects: 540
Study 14688860 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly rates of rotavirus-related episodes
Number of subjects: 540
Study 2457305 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine hydrochloride (0.5 to 2.0 micrograms/kg/min)
Number of subjects: 12
Study 2457305 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (2.5 to 10 micrograms/kg/min)
Number of subjects: 12
Study 31363748 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined household-level piped water and sanitation intervention
Number of subjects: 2398
Study 31363748 — intervention group
Group type: COMPARATOR
Intervention: Control villages
Number of subjects: 2398
Study 27497519 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon intake (two 150-g portions per week)
Number of subjects: 123
Study 27497519 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet low in oily fish)
Number of subjects: 123
Study 25998481 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec/liraglutide (IDegLira)
Number of subjects: 0
Study 25998481 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec (IDeg)
Number of subjects: 0
Study 25998481 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 0
Study 23790990 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory parent-focused approach in preschools
Number of subjects: 826
Study 23790990 — intervention group
Group type: COMPARATOR
Intervention: State-sponsored program with twice-weekly gym classes
Number of subjects: 826
Study 21627396 — intervention group
Group type: EXPERIMENTAL
Intervention: PIVC with blood control (BD Insyte Autoguard * BC Shielded IV Catheter)
Number of subjects: 234